SLC7A8 Knockout HEK293 Cell Line
Cat.No.:
EDC08226
Species:
Human
Cell Name:
HEK293
Gene:
SLC7A8
Gene ID:
23428
Size:
1×10⁶cells
SLC7A8 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08226 |
|---|---|
| Product Name | SLC7A8 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SLC7A8 |
| NCBI Gene ID | |
| Gene Synonyms | LAT2|LPI-PC1 |
| Summary |
Enables several functions, including neutral L-amino acid transmembrane transporter activity; protein heterodimerization activity; and secondary active transmembrane transporter activity. Involved in L-alanine import across plasma membrane; L-leucine import across plasma membrane; and thyroid hormone transport. Located in basolateral plasma membrane and microvillus membrane. [provided by Alliance of Genome Resources, Jul 2025]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC7A8 function, SLC7A8 Knockout HEK293 Cell Line or SLC7A8 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SLC7A8 (LAT2)'s role as a heterodimeric amino acid transporter or its specific contributions to small neutral amino acid transport in tissues like kidney and small intestine. The Knockout line is the standard tool for asking whether LAT2 is required for system L-like transport of broad-range amino acids — LAT2 partners with 4F2hc/CD98 to form a functional heterodimeric exchanger. Overexpression is useful for transport kinetics studies, but functional surface expression requires 4F2hc coexpression.
For amino acid transporter research, the EDITGENE SLC7A8 Knockout in HEK293 is a standard mechanistic platform. Note that LAT2 and LAT1 (SLC7A5) have partially overlapping substrate scopes but distinct affinity profiles — LAT2 has broader substrate range including small neutral amino acids. Rescue with wild-type or transport-deficient LAT2 enables structure-function dissection.
What are the application scenarios for this model?
Primary applications:
• Amino acid uptake assays: cellular uptake of radiolabeled small/medium neutral amino acids (alanine, serine, threonine, leucine) to assess LAT2 transport activity.
• 4F2hc partnership studies: co-expression analysis with 4F2hc (CD98)/SLC3A2 to characterize functional heterodimer formation.
• LAT1/LAT2 specificity: comparison with LAT1 (also available from EDITGENE) for paralog-specific substrate scope characterization.
• Inhibitor screening: critical genetic control for testing LAT2-selective compounds.
EDITGENE recommends this model for researchers investigating heterodimeric amino acid transporter biology and LAT family substrate specificity.
Is this SLC7A8 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. LAT2 rescue experiments require attention to heterodimer partnership requirements:
• Construct design: use a codon-modified SLC7A8 sequence with a small C-terminal tag (FLAG, HA). LAT2 has 12 transmembrane domains — N-terminal tags must not disrupt membrane topology.
• 4F2hc co-expression: LAT2 requires 4F2hc/CD98/SLC3A2 for functional surface expression — rescue cells should be characterized for 4F2hc expression, or co-rescue with 4F2hc may be needed in 4F2hc-low backgrounds.
• Transport-deficient rescue: substrate-binding pocket mutations enable distinguishing transport activity from non-transport functions.
• Functional readout: rescue should restore small/medium neutral amino acid uptake measured by radiolabel or LC-MS detection.
HEK293 transduces efficiently with lentivirus and supports the bicistronic or co-rescue strategies often needed for heterodimeric transporter studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download